Signaling alterations in activation-induced nonresponsive CD8 T cells

J Immunol. 2001 Aug 15;167(4):2040-8. doi: 10.4049/jimmunol.167.4.2040.

Abstract

Costimulation-dependent production and autocrine use of IL-2 by activated CD8 T cells results in initial clonal expansion, but this is transient. The cells quickly become anergic, unable to produce IL-2 in response to Ag and costimulation, irrespective of the form of costimulation. This activation-induced non-responsiveness (AINR) differs from "classical" anergy in that it results despite the cells receiving both signal 1 and signal 2. AINR cells can still proliferate in response to exogenous IL-2, but can no longer produce it. Other TCR-mediated events including cytolytic function and IFN-gamma production are not affected in the AINR state. To characterize the mechanism(s) responsible for lack of IL-2 production in CD8 T cells in the AINR state, microspheres bearing immobilized anti-TCR Abs or peptide-MHC complexes, B7-1, and ICAM-1 were used to provide well-defined stimuli to the cells. Comparison of normal and AINR cells revealed that in AINR cells extracellular signal-regulated kinase (ERK) is upregulated more transiently, Janus kinase activation is substantially reduced, and activation of p38 is eliminated. PMA and ionomycin restored proliferation and IL-2 production in AINR cells, indicating a signaling defect upstream of Ras and protein kinase C. Inhibitors of ERK (PD98059) and of p38 kinase (SB202190) blocked IL-2 mRNA expression and proliferation of both peptide-MHC/B7-1/ICAM-1-stimulated normal cells and PMA/ionomycin-stimulated AINR cells. Together these results demonstrate that activation of at least ERK and p38 is essential for IL-2 production by CD8 T cells and that up-regulation of these mitogen-activated protein kinases, along with Janus kinase, is defective in AINR cells.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology
  • B7-1 Antigen / immunology
  • B7-1 Antigen / metabolism
  • CD8-Positive T-Lymphocytes / enzymology*
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism
  • Clonal Anergy* / genetics
  • Enzyme Activation / immunology
  • Intercellular Adhesion Molecule-1 / immunology
  • Intercellular Adhesion Molecule-1 / metabolism
  • Interleukin-2 / antagonists & inhibitors
  • Interleukin-2 / biosynthesis
  • Ionomycin / pharmacology
  • JNK Mitogen-Activated Protein Kinases
  • Lymphocyte Activation* / drug effects
  • Lymphocyte Activation* / genetics
  • MAP Kinase Signaling System / genetics
  • MAP Kinase Signaling System / immunology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Microspheres
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / metabolism
  • Mitogen-Activated Protein Kinases / physiology
  • RNA, Messenger / antagonists & inhibitors
  • RNA, Messenger / biosynthesis
  • Tetradecanoylphorbol Acetate / pharmacology
  • Up-Regulation / genetics
  • Up-Regulation / immunology
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Antibodies, Monoclonal
  • B7-1 Antigen
  • Interleukin-2
  • RNA, Messenger
  • Intercellular Adhesion Molecule-1
  • Ionomycin
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Tetradecanoylphorbol Acetate